KRW 246000.0
(0.2%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 517.88 Billion KRW | -8.77% |
2022 | 567.67 Billion KRW | 3.77% |
2021 | 547.04 Billion KRW | -16.61% |
2020 | 656.02 Billion KRW | -12.0% |
2019 | 745.45 Billion KRW | 32.21% |
2018 | 563.85 Billion KRW | 31.44% |
2017 | 428.97 Billion KRW | 112.52% |
2016 | 201.84 Billion KRW | -11.89% |
2015 | 229.09 Billion KRW | 4.26% |
2014 | 219.74 Billion KRW | 3.85% |
2013 | 211.6 Billion KRW | -18.05% |
2012 | 258.2 Billion KRW | -6.93% |
2011 | 277.42 Billion KRW | -4.83% |
2010 | 291.49 Billion KRW | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 471.05 Billion KRW | 6.9% |
2024 Q1 | 440.63 Billion KRW | -14.92% |
2023 Q4 | 517.88 Billion KRW | 33.53% |
2023 Q1 | 493.72 Billion KRW | -13.03% |
2023 FY | 517.88 Billion KRW | -8.77% |
2023 Q3 | 387.85 Billion KRW | -10.44% |
2023 Q2 | 433.08 Billion KRW | -12.28% |
2022 Q4 | 567.67 Billion KRW | 25.19% |
2022 FY | 567.67 Billion KRW | 3.77% |
2022 Q1 | 581.79 Billion KRW | 6.35% |
2022 Q2 | 505.66 Billion KRW | -13.09% |
2022 Q3 | 453.46 Billion KRW | -10.32% |
2021 Q2 | 613.25 Billion KRW | -8.95% |
2021 Q1 | 673.5 Billion KRW | 2.66% |
2021 Q3 | 540.15 Billion KRW | -11.92% |
2021 FY | 547.04 Billion KRW | -16.61% |
2021 Q4 | 547.04 Billion KRW | 1.28% |
2020 Q3 | 745.08 Billion KRW | -4.46% |
2020 Q2 | 779.89 Billion KRW | 2.86% |
2020 FY | 656.02 Billion KRW | -12.0% |
2020 Q1 | 758.21 Billion KRW | 1.71% |
2020 Q4 | 656.02 Billion KRW | -11.95% |
2019 Q2 | 748.76 Billion KRW | 13.65% |
2019 FY | 745.45 Billion KRW | 32.21% |
2019 Q4 | 745.45 Billion KRW | -1.05% |
2019 Q3 | 753.36 Billion KRW | 0.61% |
2019 Q1 | 658.83 Billion KRW | 16.85% |
2018 Q4 | 563.85 Billion KRW | -2.12% |
2018 Q3 | 576.06 Billion KRW | 4.54% |
2018 Q2 | 551.02 Billion KRW | 18.09% |
2018 FY | 563.85 Billion KRW | 31.44% |
2018 Q1 | 466.6 Billion KRW | 8.77% |
2017 Q4 | 428.97 Billion KRW | 18.89% |
2017 FY | 428.97 Billion KRW | 112.52% |
2017 Q2 | 289.99 Billion KRW | 34.77% |
2017 Q3 | 360.82 Billion KRW | 24.43% |
2017 Q1 | 215.17 Billion KRW | 6.6% |
2016 Q2 | 53.36 Billion KRW | 160.61% |
2016 Q4 | 201.84 Billion KRW | 40.07% |
2016 Q3 | 144.1 Billion KRW | 170.02% |
2016 FY | 201.84 Billion KRW | -11.89% |
2016 Q1 | -88.05 Billion KRW | -138.44% |
2015 Q3 | 317.81 Billion KRW | 32.33% |
2015 Q1 | 233.03 Billion KRW | 6.05% |
2015 Q2 | 240.16 Billion KRW | 3.06% |
2015 FY | 229.09 Billion KRW | 4.26% |
2015 Q4 | 229.09 Billion KRW | -27.91% |
2014 Q1 | 204.96 Billion KRW | -3.14% |
2014 FY | 219.74 Billion KRW | 3.85% |
2014 Q2 | 211.32 Billion KRW | 3.1% |
2014 Q4 | 219.74 Billion KRW | 13.92% |
2014 Q3 | 192.89 Billion KRW | -8.72% |
2013 Q4 | 211.6 Billion KRW | -2.44% |
2013 Q2 | 226.77 Billion KRW | -5.09% |
2013 FY | 211.6 Billion KRW | -18.05% |
2013 Q1 | 238.94 Billion KRW | -7.46% |
2013 Q3 | 216.89 Billion KRW | -4.35% |
2012 FY | 258.2 Billion KRW | -6.93% |
2012 Q2 | 281.54 Billion KRW | -7.17% |
2012 Q3 | 271.94 Billion KRW | -3.41% |
2012 Q4 | 258.2 Billion KRW | -5.05% |
2012 Q1 | 303.29 Billion KRW | 0.0% |
2011 Q2 | 254.22 Billion KRW | -8.87% |
2011 Q3 | 244.35 Billion KRW | -3.88% |
2011 FY | 277.42 Billion KRW | -4.83% |
2011 Q1 | 278.98 Billion KRW | 0.0% |
2010 Q3 | 254.79 Billion KRW | 0.0% |
2010 FY | 291.49 Billion KRW | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Samil Pharmaceutical Co.,Ltd | 174.97 Billion KRW | -195.981% |
JW Pharmaceutical Corporation | 154.37 Billion KRW | -235.481% |
Yuhan Corporation | -69.18 Billion KRW | 848.537% |
Yuyu Pharma, Inc. | 8.8 Billion KRW | -5783.561% |
Ildong Holdings Co., Ltd. | 310.87 Billion KRW | -66.591% |
Dong Sung Bio Pharm.Co.,Ltd. | 36.83 Billion KRW | -1305.872% |
HANDOK Inc. | 283.45 Billion KRW | -82.705% |
Ilyang Pharmaceutical Co.,Ltd | 75.67 Billion KRW | -584.358% |
Kwang Dong Pharmaceutical Co., Ltd. | 158.29 Billion KRW | -227.161% |
Hanall Biopharma Co.,Ltd | -32.43 Billion KRW | 1696.84% |
MYUNGMOON Pharm co.,Ltd | 82.52 Billion KRW | -527.587% |
Daewoong pharmaceutical Co.,Ltd | 358.17 Billion KRW | -44.589% |
REYON Pharmaceutical Co., Ltd. | 200.94 Billion KRW | -157.723% |
Dong-A ST Co., Ltd. | 193.95 Billion KRW | -167.02% |
Ildong Pharmaceutical Co., Ltd. | 164.58 Billion KRW | -214.666% |
Dong-A Socio Holdings Co., Ltd. | 572.02 Billion KRW | 9.464% |
Jeil Pharma Holdings Inc | 135.99 Billion KRW | -280.822% |
Aprogen pharmaceuticals,Inc. | 170.94 Billion KRW | -202.957% |
Hyundai Pharmaceutical Co., Ltd. | 23 Billion KRW | -2151.537% |
Dongwha Pharm.Co.,Ltd | -24.06 Billion KRW | 2252.324% |
Shin Poong Pharm.Co.,Ltd. | 2.35 Billion KRW | -21925.337% |
CKD Bio Corp. | 143.29 Billion KRW | -261.409% |
Yuyu Pharma, Inc. | 8.8 Billion KRW | -5783.561% |
JW Pharmaceutical Corporation | 154.37 Billion KRW | -235.481% |
Kukje Pharma Co., Ltd. | 20.07 Billion KRW | -2480.118% |
Samjin Pharmaceuticals Co., Ltd. | 116.23 Billion KRW | -345.545% |
Hana Pharm Co., Ltd. | 25.1 Billion KRW | -1962.6% |
Chong Kun Dang Holdings Corp. | 422.84 Billion KRW | -22.478% |
JW Pharmaceutical Corporation | 154.37 Billion KRW | -235.481% |
Daewon Pharmaceutical Co., Ltd. | 116.06 Billion KRW | -346.195% |
Whan In Pharm Co.,Ltd. | -44.73 Billion KRW | 1257.698% |
Chong Kun Dang Pharmaceutical Corp. | 117.53 Million KRW | -440536.026% |
Yuyu Pharma, Inc. | 8.8 Billion KRW | -5783.561% |
Yuhan Corporation | -69.18 Billion KRW | 848.537% |
SAMSUNG PHARM. Co., LTD. | -3.68 Billion KRW | 14150.785% |
Ilsung Pharmaceuticals Co., Ltd. | -159.84 Billion KRW | 423.988% |
Yungjin Pharm. Co., Ltd. | 59.67 Billion KRW | -767.855% |
Korea United Pharm Inc. | 16.42 Billion KRW | -3053.014% |
JW Holdings Corporation | 480.68 Billion KRW | -7.738% |
Suheung Co., Ltd. | 429.14 Billion KRW | -20.678% |
Jeil Pharmaceutical Co.,Ltd | 51.97 Billion KRW | -896.421% |
Shin Poong Pharm.Co.,Ltd. | 2.35 Billion KRW | -21925.337% |
Boryung Corporation | 187.72 Billion KRW | -175.87% |
Bukwang Pharmaceutical Co., Ltd. | -71.84 Billion KRW | 820.887% |
Ilyang Pharmaceutical Co.,Ltd | 75.67 Billion KRW | -584.358% |
JW Lifescience Corporation | 26.09 Billion KRW | -1884.945% |